ZYNRELEF® and APONVIE® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise– Achieved $154.9 Million in 2025 Net Revenue– Issues ...
MicroCloud Hologram Inc. , ("HOLO" or the "Company"), a technology service provider, has developed a surface code quantum simulator based on FPGA. This innovative technology marks a new milestone in ...
If ski jumpers really are injecting hyaluronic acid into their crotches to gain an advantage, it appears they aren’t doing anything illegal.
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q4 2025 Earnings Call Transcript February 17, 2026 Halozyme Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.20327 EPS, expectations ...
Q4 2025 Earnings Call February 24, 2026 9:00 AM ESTCompany ParticipantsJeff Borcherding - Global Chief Executive Officer ...
Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise- Achieved $154.9 Million in 2025 Net Revenue- Issues Full-Year 2026 Net Revenue Guidance of $173 to $183 ...
Therapeutic antibodies packaged into microparticles could be delivered with a standard syringe, avoiding the need for lengthy ...
Before the infusion was complete, she died of sudden cardiac arrest. An autopsy failed to find a cause of her death, but experts were concerned that the potassium included in the hydration might have ...
As I look back on the past year, it is clear that 2025 was one of the most significant and value-creating years in Halozyme ...
EAE-induced neuroinflammation. Using immuohistochemistry, flow cytometry, and single-cell RNAseq of doublets to interrogate cell-cell interactions, the authors provide solid evidence that macrophages, ...
The new Category III CPT code will be published on July 1, 2026 and will become effective for reporting on January 1, 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results